Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: A randomized controlled trial

Reproductive Biology and Endocrinology

Volumn 16, Issue 1, 2018, Pages

  Xu, Yangying ^a,b,c   Nisenblat, Victoria ^b,c   Lu, Cuiling ^b,c   Li, Rong ^b,c   Qiao, Jie ^b,c   Zhen, Xiumei ^b,c   Wang, Shuyu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Clinical outcomes; Coenzyme Q10; High quality embryos; In vitro fertilization; Oxidative stress; Poor ovarian response; POSEIDON stratification

Indexed keywords

ESTROGEN; GONADOTROPIN; UBIDECARENONE; ANTIOXIDANT; UBIQUINONE;

ADULT; ARTICLE; BIRTH RATE; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; HUMAN; IN VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY INSUFFICIENCY; OVULATION INDUCTION; POOR OVARIAN RESPONSE; PREGNANCY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; DRUG EFFECT; EMBRYO CULTURE; LIVE BIRTH; OVARY DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY;

ADULT; ANTIOXIDANTS; CRYOPRESERVATION; EMBRYO CULTURE TECHNIQUES; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; LIVE BIRTH; OOCYTE RETRIEVAL; OVARIAN DISEASES; OVARIAN RESERVE; OVULATION INDUCTION; PREGNANCY; PROGNOSIS; PROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME; UBIQUINONE;

EID: 85044510429     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/s12958-018-0343-0     Document Type: Article

References (39)

1. Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL. The poor responder in IVF: is the prognosis always poor? A systematic review. Hum Reprod Update. 2012;18:1-11.
2. Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S. Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev. 2010;20:CD004379.
3. Szymusik I, Marianowski P, Zygula A, Wielgos M. Poor responders in IVF, is there any evidence based treatment for them? Neuro Endocrinol Lett. 2015;36:209-13.
4. Patrizio P, Vaiarelli A, Setti L, Tobler KJ, Shoham G, Leong M, et al. How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics. Reprod BioMed Online. 2015;30:581-92.
5. Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: reliability and utility. Curr Opin Obstet Gynecol. 2010;22:271-6.
6. Papathanasiou A, Searle BJ, King NM. Trends in 'poor responder' research: lessons learned from RCTs in assisted conception. Hum Reprod Update. 2016;22
7. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the bologna criteria. Hum Reprod. 2011;26:1616-24.
8. Szymusik I, Marianowski P, Zygula A, Wielgos M. Management of poor responders in IVF: is there anything new? Biomed Res Int. 2014;2014:352098.
9. Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452-3.
10. Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of 'low prognosis women in assisted reproductive technology' and its proposed marker of successful outcome[J]. F1000research. 2016;5:2911.
11. Blerkom JV. Mitochondrial function in the human oocyte and embryo and their role in developmental competence. Mitochondrion. 2011;11:797-813.
12. Nickel A, Kohlhaas M, Maack C. Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol. 2014;73:26-33.
13. Wilson DM 3rd, Sofinowski TM, McNeill DR. Repair mechanisms for oxidative DNA damage. Front Biosci. 2003;8:d963-81.
14. Bentov Y, Casper RF. The aging oocyte-can mitochondrial function be improved? Fertil Steril. 2013;99:18-22.
15. Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion. 2007;7:S41.
16. Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors. 2003;18:91-100.
17. Balercia G, Mosca F, Mantero F, Boscaro M, Mancini A, Ricciardo-Lamonica G, et al. Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. Fertil Steril. 2004;81:93-8.
18. Reza Safarinejad M. The effect of coenzyme Q10 supplementation on partner pregnancy rate in infertile men with idiopathic oligo astheno teratozoospermia: an open-label prospective study. Int Urol Nephrol. 2012;44:689-700.
19. Mancini A, Festa R, Raimondo S, Pontecorvi A, Littarru GP. Hormonal influence on coenzyme Q10 levels in blood plasma. Int J Mol Sci. 2011;12:9216-25.
20. Miles MV, Horn PS, Tang PH, Morrison JA, Miles L, DeGrauw T, Pesce AJ. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta. 2004;347:139-44.
21. Ben-Meir A, Burstein E, Borrego-Alvarez A, Chong J, Wong E, Yavorska T, et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell. 2015;14:887-95.
22. Ozcan P, Ficicioglu C, Kizilkale O, Yesiladali M, Tok OE, Ozkan F, et al. Can coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage? J Assist Reprod Genet. 2016;33:1223-30.
23. Marriage BJ, Clandinin MT, Macdonald IM, Glerum DM. Cofactor treatment improves ATP synthetic capacity in women with oxidative phosphorylation disorders. Mol Genet Metab. 2004;81:263-72.
24. El Refaeey A, Selem A, Badawy A. Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. Reprod BioMed Online. 2014;29:119-24.
25. Bentov Y, Hannam T, Jurisicova A, Esfandiari N, Casper RF. Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment. Clin Med Insights Reprod Health. 2014;8:31-6.
26. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270-83. https://doi.org/10.1093/humrep/der037.
27. Gat I, Blanco Mejia S, Balakier H, Librach CL, Claessens A, Ryan EA. The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve. Gynecol Endocrinol. 2016; https://doi.org/10.3109/09513590.2015.1137095.
28. Torner H, Brüssow KP, Alm H, Ratky J, Pöhland R, Tuchscherer A, Kanitz W. Mitochondrial aggregation patterns and activity in porcine oocytes and apoptosis in surrounding cumulus cells depends on the stage of pre-ovulatory maturation. Theriogenology. 2004;61:1675-89.
29. Fragouli E, Wells D. Mitochondrial DNA assessment to determine oocyte and embryo viability. Semin Reprod Med. 2015;33:401-9.
30. Meldrum DR. Aging gonads, glands, and gametes: immutable or partially reversible changes? Fertil Steril. 2013;99(1):1-4.
31. Bentov Y, Yavorska T, Esfandiari N, Jurisicova A, Casper RF. The contribution of mitochondrial function to reproductive aging. J Assist Reprod Genet. 2011;28:773-83.
32. Crane FL. The evolution of coenzyme Q. Biofactors. 2008;32:5-11.
33. Burstein E, Perumalsamy A, Bentov Y, Esfandiari N, Jurisicova A, Casper RF. Co-enzyme Q10 supplementation improves ovarian response and mitochondrial function in aged mice. Fertil Steril. 2009;92:S31.
34. Turi A, Giannubilo SR, Brugè F, Principi F, Battistoni S, Santoni F, et al. Coenzyme Q10 content in follicular fluid and its relationship with oocyte fertilization and embryo grading. Arch Gynecol Obstet. 2012;285:1173-6.
35. Akarsu S, Gode F, IsikA Z, Günnur Dikmen Z, Agah Tekindal M. The association between coenzyme Q10 concentrations in follicular fluid with embryo morphokinetics and pregnancy rate in assisted reproductive techniques. J Assist Reprod Genet. 2017;34:599-605.
36. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121-55.
37. Visser JA, Schipper I, Laven JSE, Themmen APN. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8:331-41.
38. Ikematsu H, Nakamura K, Harashima S, Fujii K, Fukutomi N. Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial. Regul Toxicol Pharmacol. 2006;44:212-8.
39. Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF. Treatment for mitochondrial disorders. Cochrane Database Syst Rev. 2012;4(4):CD004426.